Associated Papers
Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis.
Cacciottolo TM et al.
Diabetes, 2025
The Glucagon Receptor Is Expressed in the Frontal Cortex and Impaired Signaling Associates With Cognitive Decline.
Kjeldsen SAS et al.
Journal of the Endocrine Society, 2025
Absence of PNET formation and normal longevity in a mouse model of Mahvash disease.
Xu Y et al.
Heliyon, 2024
Determinants of plasma levels of proglucagon and the metabolic impact of glucagon receptor signalling: a UK Biobank study.
Winther-Sørensen M et al.
Diabetologia, 2024
Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease.
Sipos B et al.
Endocrine-related Cancer, 2023
Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis.
Liu Q et al.
Bioscience Reports, 2021
The V369M Gcgr knock-in mice are a precision medicine model of mild Mahvash disease.
Yu R
The Biochemical Journal, 2020
Characterization of a naturally occurring mutation V368M in the human glucagon receptor and its association with metabolic disorders.
Lin G et al.
The Biochemical Journal, 2020
Increased SLC38A4 Amino Acid Transporter Expression in Human Pancreatic α-Cells After Glucagon Receptor Inhibition.
Kim J et al.
Endocrinology, 2019
The first pediatric case of glucagon receptor defect due to biallelic mutations in GCGR is identified by newborn screening of elevated arginine.
Li H et al.
Molecular Genetics and Metabolism Reports, 2018
Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations.
Sipos B et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
Select a paper to view details